Premarket Mover: Telesis Bio Inc (DNAY) Down 3.33%

Friday, November 25, 2022 08:37 AM | InvestorsObserver Analysts

Mentioned in this article

Premarket Mover: Telesis Bio Inc (DNAY) Down 3.33%

Telesis Bio Inc (DNAY) has fallen Friday morning, with the stock losing -3.33% in pre-market trading to 1.45. DNAY's short-term technical score of 60 indicates that the stock has traded more bullishly over the last month than 60% of stocks on the market. In the Medical Devices industry, which ranks 119 out of 146 industries, the stock ranks higher than 70% of stocks. Telesis Bio Inc has fallen 21.47% over the past month, closing at $1.69 on October 28. During this period of time, the stock fell as low as $1.45 and as high as $1.92. DNAY has an average analyst recommendation of Strong Buy. The company has an average price target of $6.50.

DNAY has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on DNAY!

See Full DNAY Report

Telesis Bio Inc has a Long-Term Technical rank of 21. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 79% of the market scoring higher. In the Medical Devices industry which is number 123 by this metric, DNAY ranks better than 123% of stocks.

Important Dates for Investors in DNAY:

-Telesis Bio Inc is set to release earnings on 2/6/2023. Over the last 12 months, the company has reported EPS of $-1.68. -We do not have a set dividend date for Telesis Bio Inc at this time. Click Here To Get The Full Report on Telesis Bio Inc (DNAY)